Name: Tang Yongmin
Gender: Male
Affiliation: Department of Pediatrics and Division of Hematology-oncology, Children’s Hospital of Zhejiang University School of Medicine
Current Titles: Director, Pediatric Department, Division Head, Division of Hematology-oncology, Deputy Director, Central Laboratory
Academic and Social Titles:
Member of American Society of Hematology (ASH)
Member of International Society of Pediatric Oncology (SIOP)
Collaborator of 7th and 8th International Workshop and Conference on Human Leukocyte Differentiation Antigens
Vice Chairman and Board Member of National Pediatric Oncology Committee in Chinese Anti-cancer Society
Vice Chairman and Board Member of Pediatric Oncology Committee in Zhejiang Province
Board Member of Zhejiang Branch of the Tumor Marker Committee in Chinese Anti-Cancer Society
Board Member of Zhejiang Branch of the Hematology Society in Chinese Medical Association
Deputy Editor-in-chief and Editing Board Member, Chinese Journal of Pediatric Hematology-oncology
Editing Board Member of Chinese Journal of Pediatrics
Editing Board Member, International Journal of Pediatrics
Editing Board Member of the Chinese Journal of Experimental Hematology
Editing Board Member, International Journal of transfusion and Hematology
Educations:
USA: MD equivalent, Certified by ECFMG in USA， Certificate No: 0-536-196－9) post-doctor research fellow
China: Master Degree in Medical Science
Contact information:
e-mail: bbqty@mail.hz.zj.cn
Mailing address: #57 Zhuganxiang Road, Yan-an Street, Hangzhou 310003, China
Additional Information:
His strong area of academics includes the diagnosis and treatment as well as laboratory research on pediatric hematology-oncology. He is very familiar with profound experience on the chemotherapy and hematopoietic stem/progenitor cell transplantation for common pediatric hematological and oncological diseases including leukemia, lymphoma, neuroblastoma etc. He is also an expert on using multi-parameter flow cytometry in the diagnosis and research in pediatric and adult hematological and oncological area. He is with profound experience in the research area of pediatric hematology-oncology and immunology using cellular - molecular biology and molecular immunology.
Research interests: He is currently focusing on the study on monoclonal antibody engineering and targeting treatment for pediatric hematological malignancies particularly in leukemia and lymphoma.
He has published more than 110 peer-reviewed papers and 30 English Meeting Abstracts in both English journals and Top Journals in Chinese. He has been awarded two Pronvincial Science and Technology awards and one national patent.
Outpatient Service Time: Friday Morning
